Purchase Order 75N93023P00594
- Not listed
- This firm fixed-price purchase order for $9,150.00 was awarded to DNA Twopointo Inc. (doing business as ATUM Biosciences) by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to provide other functions related to adenovirus vector construction. The award does not have a set-aside designation. DNA Twopointo Inc. is a for-profit manufacturer that has previously received federal contracts and grants from various agencies, including NIAID, the Naval Sea Systems...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to DNA Twopointo Inc. (doing business as ATUM Biosciences) for gene card and gene synthesis services. The contract has a ceiling value of $9,500.00 and was awarded on November 15, 2011 with a final completion date of September 30, 2012. The contract is not set aside for any specific business category. DNA Twopointo Inc....
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a for-profit Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,347.40, is for DNA services including subcloning, mutagenesis, gene synthesis, and plasmid production to support NIAID's Vaccine Research Center's...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Geneimmune Biotechnology Corp, a for-profit Asian-Pacific American-owned biotechnology company based in Rockville, MD. The contract is for $151,620.00 and covers site-directed mutagenesis, gene synthesis, and plasmid preparation services in support of COVID-19 research. The contract was awarded on a sole-source basis pursuant to FAR...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $49,946.10 firm-fixed-price purchase order contract for antibody expression services to Biointron Biological USA Inc., a small disadvantaged business. The contract, which has no set-aside designation, has an ultimate completion date of July 11, 2025. The award was made on July 12, 2024. NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious and...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $210,338.00 firm fixed-price purchase order to Creative Biolabs Inc. for mouse antibody production services across Phases I through IV. The contract, which runs through September 22, 2025, does not have a set-aside designation. Creative Biolabs, a specialized biotechnology and pharmaceutical services provider, will deliver custom solutions in...
- This is a $200,219.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Geneuniversal Inc., a for-profit biotechnology services provider based in Newark, Delaware. The contract is for DNA services including antibody gene synthesis, subcloning, and plasmid preparation to support the Vaccine Research Center's (VRC) efforts to develop vaccines against HIV/AIDS. This is a follow-on requirement to...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, awarded a $25,085.25 firm-fixed-price purchase order contract to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, a foreign-owned for-profit manufacturer of specialized genomic and proteomic research tools. The contract is for the delivery of custom DNA kits, specifically MYBAITS Custom 200-250K 48 RXNS for Trypanosomes, to support NIAID's biomedical research programs. This contract is...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a $35,043 fixed-price purchase order to Trilink Biotechnologies, LLC of San Diego, California. The contract is for a standing order of N1-methyl-pseudoridine-5'-triphosphate and CleanCap reagent AG, to be delivered between August 2023 and May 2024. As part of its mission to conduct and support research on infectious and immune-mediated diseases, the National...
- <p>The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a Small Business Innovation Research (SBIR) Phase I contract to Aldatu Biosciences, Inc. for the development of a rapid, sensitive, and cost-effective method to detect drug-resistant HIV minority variants. The contract, valued at $298,690.00, is a Definitive Contract with a Firm Fixed Price pricing type. The contract has an ultimate completion date of December 14, 2017.</p>
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded a $375,000.00 sole source contract to DNA Twopointo Inc., doing business as ATUM Biosciences, for a license to use ATUM's proprietary cell line technology for the production of an engineered antibody (PGDM1400.LS) to support ongoing AIDS clinical trials. The contract has a one-year base period starting May 14, 2023, with four one-year option periods extending to May 13, 2028. There is no set-aside designation for this award. ATUM Biosciences, a small business manufacturer, has previously provided gene synthesis, cell line development, and other services to various federal agencies, including the Naval Sea Systems Command, NASA, and the NIH Vaccine Research Center.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
License Renewal for Protein Expressing Cell Line | NOI-NIAID-23-2168820 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Pre-Solicitation 1/1 | 4/13/23, 9:07 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $75.0k | 4/24/25 | |
| P00001 | Exercise an Option | $75.0k | 5/6/24 | |
| Not listed | Not listed | $75.0k | 5/12/23 |